Evidence map›Paper›PMID 9600980›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1998

t(11;22)(q23;q11.2) In acute myeloid leukemia of infant twins fuses MLL with hCDCrel, a cell division cycle gene in the genomic region of deletion in DiGeorge and velocardiofacial syndromes.

M D Megonigal, E F Rappaport, D H Jones, T M Williams, B D Lovett, K M Kelly, P H Lerou, T Moulton, M L Budarf, C A Felix

Erratum issuedOpen access · greenAbstract readCase Reports
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
8.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 160 citations in OpenAlex.

  1. Review
  2. Article
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Acute myeloid leukemia withSAGE open medical case reports · 2018
    Article
  10. The Mammalian Septin Interactome.Frontiers in cell and developmental biology · 2017
    Review
  11. Article
  12. Article
  13. Article
  14. Topoisomerase II and leukemia.Annals of the New York Academy of Sciences · 2014
    Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Septin expression in proliferative retinal membranes.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2007
    Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

M D MegonigalDivision of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
E F Rappaport
D H Jones
T M Williams
B D Lovett
K M Kelly
P H Lerou
T Moulton
M L Budarf
C A Felix
University of Iowa · USUniversity of Pennsylvania · USColumbia University · USChildren's Hospital of Philadelphia · US

Funding

VELOCARDIOFACIAL SYNDROME--MOLECULAR &CLINICAL STUDIESP01DC002027 · NIDCD · CHILDREN'S HOSPITAL OF PHILADELPHIA · PI EMANUEL, BEVERLY S · 1994 to 2003
$6.4M
SCOR IN PEDIATRIC CARDIOVASCULAR DISEASEP50HL051533 · NHLBI · CHILDREN'S HOSPITAL OF PHILADELPHIA · PI BUCK, CLAYTON A · 1993 to 1998
–
EPIPODOPHYLLOTOXIN ASSOCIATED SECONDARY LEUKEMIAR29CA066140 · NCI · CHILDREN'S HOSPITAL OF PHILADELPHIA · PI FELIX, CAROLYN A · 1995 to 1999
–
NCI NIH HHS 1R29CA66140-03NHLBI NIH HHS HL51533NIDCD NIH HHS DC02027NIDCD NIH HHS P01 DC002027
6 · The paper itself

Abstract

We examined the MLL genomic translocation breakpoint in acute myeloid leukemia of infant twins. Southern blot analysis in both cases showed two identical MLL gene rearrangements indicating chromosomal translocation. The rearrangements were detectable in the second twin before signs of clinical disease and the intensity relative to the normal fragment indicated that the translocation was not constitutional. Fluorescence in situ hybridization with an MLL-specific probe and karyotype analyses suggested t(11;22)(q23;q11. 2) disrupting MLL. Known 5' sequence from MLL but unknown 3' sequence from chromosome band 22q11.2 formed the breakpoint junction on the der(11) chromosome. We used panhandle variant PCR to clone the translocation breakpoint. By ligating a single-stranded oligonucleotide that was homologous to known 5' MLL genomic sequence to the 5' ends of BamHI-digested DNA through a bridging oligonucleotide, we formed the stem-loop template for panhandle variant PCR which yielded products of 3.9 kb. The MLL genomic breakpoint was in intron 7. The sequence of the partner DNA from band 22q11.2 was identical to the hCDCrel (human cell division cycle related) gene that maps to the region commonly deleted in DiGeorge and velocardiofacial syndromes. Both MLL and hCDCrel contained homologous CT, TTTGTG, and GAA sequences within a few base pairs of their respective breakpoints, which may have been important in uniting these two genes by translocation. Reverse transcriptase-PCR amplified an in-frame fusion of MLL exon 7 to hCDCrel exon 3, indicating that an MLL-hCDCrel chimeric mRNA had been transcribed. Panhandle variant PCR is a powerful strategy for cloning translocation breakpoints where the partner gene is undetermined. This application of the method identified a region of chromosome band 22q11.2 involved in both leukemia and a constitutional disorder.

Indexed as

Chromosomes, Human, Pair 11Chromosomes, Human, Pair 22Diseases in TwinsProto-OncogenesTranscription FactorsTranslocation, GeneticAbnormalities, MultipleAcute DiseaseBase SequenceCell Cycle ProteinsDiGeorge SyndromeDNA-Binding ProteinsFaceGene DeletionGenome, HumanHeart Defects, CongenitalCell Cycle ProteinsDNA-Binding ProteinsHistone-Lysine N-MethyltransferaseKMT2A protein, humanMyeloid-Lymphoid Leukemia ProteinTranscription Factors

Identifiers

PMID9600980
PMCPMC27754
OpenAlexW1988582699

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.